Literature DB >> 8317553

Ultrastructural localization of DNA in immune deposits of human lupus nephritis.

D Malide1, I Londoño, P Russo, M Bendayan.   

Abstract

DNA molecules were revealed in the glomerular wall of lupus nephritis patients by applying two specific colloidal gold cytochemical approaches at the electron microscope level: immunocytochemistry using a monoclonal anti-DNA antibody in conjunction with protein A-gold and enzyme-gold cytochemistry using DNAse-gold complexes. Application of both techniques has demonstrated that DNA molecules are preferentially located over the electron-dense deposits found in the glomerular basement membrane and mesangial matrix of SLE patients, as well as over the nuclei. Their distribution within the glomerular wall was correlated with electron-dense immune deposits revealed by anti-light chain antibodies. In normal control kidney, DNA labeling was restricted to the cell nuclei. Several control experiments have demonstrated the high specificity of the results. These data thus suggest a possible role for DNA as an antigenic component in the formation of immune complexes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8317553      PMCID: PMC1886959     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Systemic lupus erythematosus: prototype of immune complex nephritis in man.

Authors:  D Koffler; V Agnello; R Thoburn; H G Kunkel
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

2.  Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.

Authors:  E M Tan; P H Schur; R I Carr; H G Kunkel
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

3.  Ultrastructural localization of nuclei acids by the use of enzyme-gold complexes.

Authors:  M Bendayan
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  In situ immune complex formation and glomerular injury.

Authors:  W G Couser; D J Salant
Journal:  Kidney Int       Date:  1980-01       Impact factor: 10.612

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus.

Authors:  D Koffler; V Agnello; H G Kimkel
Journal:  Am J Pathol       Date:  1974-01       Impact factor: 4.307

7.  Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.

Authors:  G A Andres; L Accinni; S M Beiser; C L Christian; G A Cinotti; B F Erlanger; K C Hsu; B C Seegal
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

8.  In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus.

Authors:  S Izui; P H Lambert; P A Miescher
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

9.  Immunologic studies of autoimmune disease in NZB-NZW F1 mice. I. Binding of fluorescein-labeled antinucleoside antibodies in lesions of lupus-like nephritis.

Authors:  B C Seegal; L Accinni; G A Andres; S M Beiser; C L Christian; B F Erlanger; K Hsu
Journal:  J Exp Med       Date:  1969-08-01       Impact factor: 14.307

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  4 in total

1.  Acquired loss of renal nuclease activity is restricted to DNaseI and is an organ-selective feature in murine lupus nephritis.

Authors:  Natalya Seredkina; Ole P Rekvig
Journal:  Am J Pathol       Date:  2011-06-30       Impact factor: 4.307

2.  Pharmacodynamics of recombinant human DNase I in serum.

Authors:  W S Prince; D L Baker; A H Dodge; A E Ahmed; R W Chestnut; D V Sinicropi
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

3.  Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus.

Authors:  J B Lefkowith; M Kiehl; J Rubenstein; R DiValerio; K Bernstein; L Kahl; R L Rubin; M Gourley
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

4.  Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis.

Authors:  Svetlana N Zykova; Anders A Tveita; Ole Petter Rekvig
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.